Chronic Pain and InflammationMore Areas Of CareToljan K, Vrooman B. Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. Med Sci (Basel), 2018;6(4)View study
Chronic Pain and InflammationMore Areas Of CareTraish A, Bolanos J, Nair S, Saad F , Morgentaler A. Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence. J Clin Med, 2018; 7(12). pii: E549View study
Chronic Pain and InflammationMore Areas Of CareYang J, Shin KM, Do A, Bierle DM, Abu Dabrh AM, Yin Z, Bauer BA, Mohabbat AB. The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review. J Pain Res. 2023 Mar 21;16:1017-1023. View study
MenopauseGandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016 Dec;215(6):704-711. View study
MenopauseFaubion SS, Sood R, Kapoor E. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician. Mayo Clin Proc. 2017 Dec;92(12):1842-1849.View study
MenopauseDavis SR, Wahlin-Jacobsen S. Testosterone in women–the clinical significance. Lancet Diabetes Endocrinol. 2015 Dec;3(12):980-92. View study
MenopauseBramwell BL. The clinical use of dehydroepiandrosterone in postmenopausal women. Int J Pharm Compd. 2010 Nov-Dec;14(6):465-71.View study
MenopauseAli ES, Mangold C, Peiris AN. Estriol: emerging clinical benefits. Menopause. 2017 Sep;24(9):1081-1085. View study
